Edison Pharmaceuticals Lands $50,000,135 New Funding

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=7e938c2a-6d18-4892-8965-a6db95889051
Date
3/28/2014
Company Name
Edison Pharmaceuticals
Mailing Address
350 N. Bernardo Ave Mountain View, CA 94043 USA
Company Description
Edison’s business is the development of drugs to treat diseases that impair energy metabolism. Energy impairment diseases can be classified on the basis of whether they are inherited or acquired, and furthermore on the location of the defect. Edison is initially focusing on inherited diseases of the mitochondria- nature’s biological energy substation.
Website
http://www.edisonpharma.com
Transaction Type
Venture Equity
Transaction Amount
$50,000,135
Transaction Round
Undisclosed
Proceeds Purposes
Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for investment details, if applicable. Not an offer or solicitation for sale of securities.
M&A Terms
Venture Investor